How Investors Are Reacting To agilon health Stock After Profit Turnaround

Simply Wall St.11-13 14:29

agilon health reported third quarter 2026 revenue of US$1,519.49 million and net income of US$34.91 million, with basic earnings per share of US$2.08 after a loss in the prior year period. Across the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2683052180?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","is_english":true,"pubTime":"2026-11-13 14:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2683052180","market":"sg","top_or_hot":-1,"title":"How Investors Are Reacting To agilon health Stock After Profit Turnaround","media":"Simply Wall St.","content":"<div>\n<p>agilon health reported third quarter 2026 revenue of US$1,519.49 million and net income of US$34.91 million, with basic earnings per share of US$2.08 after a loss in the prior year period. Across the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/how-investors-are-reacting-to-agilon-health-stock-after-prof\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How Investors Are Reacting To agilon health Stock After Profit Turnaround</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow Investors Are Reacting To agilon health Stock After Profit Turnaround\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-11-13 14:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/how-investors-are-reacting-to-agilon-health-stock-after-prof><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>agilon health reported third quarter 2026 revenue of US$1,519.49 million and net income of US$34.91 million, with basic earnings per share of US$2.08 after a loss in the prior year period. Across the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/how-investors-are-reacting-to-agilon-health-stock-after-prof\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/how-investors-are-reacting-to-agilon-health-stock-after-prof","article_id":"2683052180","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-agl/agilon-health/news/how-investors-are-reacting-to-agilon-health-stock-after-prof","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2683052180","pubTimestamp":1794551394,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"BBailey PembertonNovember 13, 2026","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","BK4539":"次新股","ISBC":"投资者银行","BK4211":"区域性银行","AGL":"agilon health, inc."},"translate_title":"利润好转后投资者对 agilon health 股票的反应","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISBC":1.5,"AGL":1},"content_text":"agilon health reported third quarter 2026 revenue of US$1,519.49 million and net income of US$34.91 million, with basic earnings per share of US$2.08 after a loss in the prior year period. Across the first nine months of 2026, agilon health moved from a net loss to net income of US$101.78 million and raised full year revenue guidance to a range of US$5,870 million to US$5,890 million, which reflects management’s current view on demand and cost control. We will now look at how agilon health’s shift to profitability and higher revenue guidance could influence the broader investment narrative.  Spot opportunities across the same healthcare theme by scanning our hand-picked 35 healthcare AI stocks that are also turning earnings headlines into fresh investment stories.\nAdvertisementagilon health Investment Narrative Recap To own agilon health, an investor needs to believe the firm can keep turning its value based primary care model into durable profits, not just one strong quarter. The recent swing to quarterly and year to date net income supports that story. The key short term catalyst remains execution on medical cost control while operating within tighter contracts and exited markets. The biggest risk is still membership pressure in Medicare Advantage. If covered lives remain soft, higher revenue guidance alone may not offset the drag on operating leverage. These results help, but they do not remove concerns about slower customer growth or past cash burn raised in the analyst consensus Narrative on Simply Wall St. The raised full year revenue outlook to US$5,870 million to US$5,890 million is the announcement that really matters here. It ties directly to whether agilon health can lean on its data pipeline, AI supported risk adjustment and clinical pathways to keep medical costs in line while staying disciplined on contracts. This guidance range also tests the core catalysts that analysts focus on, such as expanding ACO programs and profitability focused growth. If the business hits its revenue range while keeping quality scores and medical margins within prior commentary, it strengthens the case that the platform can support a more stable earnings profile over time. What The agilon health Forecasts Assume agilon health's narrative projects revenues of US$7.4b and earnings of US$77.9 million by 2029. That profile is built on analysts assuming revenue grows at about 7.6% a year, and earnings move from a loss of US$251.2 million today to a gain of US$77.9 million, which is roughly a 2x swing in absolute profit compared with the size of the current loss. Uncover why agilon health's fair value indicates a 5% potential upside to its current price, which could narrow quickly. NYSE:AGL 1-Year Stock Price Chart Exploring Other Perspectives Some of the lowest agilon health forecasts leaned hard into the risk that Medicare Advantage membership keeps slipping, which they saw as a ceiling on future earnings. Those analysts were only penciling in about US$7.0b of revenue and US$14.0 million of profit by 2029. Today’s stronger results could challenge that view, so explore both narratives before deciding what you think. Explore 2 other agilon health fair value estimates, including one that suggests it could be worth just $115.83. Reach Your Own Conclusion Don't just follow the ticker; dig into the data and build a conviction that's truly your own.  A great starting point for your agilon health research is our analysis highlighting 3 key rewards that could impact your investment decision. See our latest analysis for agilon health. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate agilon health's overall financial health at a glance.  Looking for more investment ideas beyond agilon health? Once you have a view on agilon health, it can help to compare that thesis with other opportunities that match your preferred mix of quality, risk and income. The Simply Wall St Screener lets you filter for exactly the traits you care about, so you can build a watchlist that suits how you like to invest.  For investors who care most about financial resilience, start with a list of solid balance sheet and fundamentals (23 results) that can handle tougher operating conditions without stretching their finances. If you want long term compounding potential at reasonable prices, focus on 32 high quality undervalued stocks that pair quality fundamentals with what our models view as discounted market expectations. Income focused investors can zero in on companies with meaningful yields by screening for 6 dividend fortresses that combine regular payouts with underlying business strength.  This article is general in nature and was produced with the assistance of AI automation,\n        based on data and analysis from Simply Wall St. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2683052180","isCrawlerRequest":true}